Endocrinology
News, opinions and meeting coverage in endocrinology.
鈥� First positive phase III study for a GLP-1 agonist in chronic liver disease
Latest in Endocrinology
All three physicians could lose their licenses
Health news and commentary gathered by 番茄社区 staff
Addition of GLP-1 drugs led to an even greater reduction
Health news and commentary gathered by 番茄社区 staff
Addition of GLP-1 drugs led to an even greater reduction
Endocrinology Case Studies
Alcoholism, liver dysfunction highly linked with rare disease of unknown etiology
Surgery may not always be the best option, case report finds
Diagnosis of this rare disease is often a challenge
More in Endocrinology
News and commentary from the endocrinology world
Most are eligible for weight management indication
Trump's pick to lead HHS has called the mineral "industrial waste"
In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose
No adverse events resulted in treatment discontinuation
SUMMIT trial able to show clinical benefit beyond quality-of-life improvement
Also in TTHealthWatch: frailty as a predictor of dementia
These eight specialties earn the least, with many averaging less than $300k per year
Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations
One pediatric endocrinologist called it "lifesaving" for her patients
News and commentary from the endocrinology world
Plus: oral semaglutide outcomes and incident hypertension in teens on GLP-1 drugs
Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes
